Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Solid Tumors Harboring NTRK Fusion 1Recurrence 1Liver Neoplasms 1Insulin-Like Growth Factor I, Resistance To 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Breast Neoplasms, Male 1Breast Neoplasms 1Advanced Solid Tumor 1

Interventions

exemestane 2Letrozole 2seviteronel 1sargramostim 1ribociclib 1methyl N-acetylsibirosaminide 1elacestrant 1Trastuzumab 1Tamoxifen 1Suspensions 1Receptor Protein-Tyrosine Kinases 1Presenilin-1 1Pemetrexed 1Leuprolide 1Injections 1HER2 peptide (369-377) 1Granulocyte-Macrophage Colony-Stimulating Factor 1Goserelin 1Fentanyl 1Anastrozole 190Y-octreotide, DOTA-Tyr(3)- 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Breast Neoplasms, Male × Receptor Protein-Tyrosine Kinases × Clear all
NCT01570036 2020-12-02

Combination Immunotherapy With Herceptin and the HER2 Vaccine NeuVax

Cancer Insight, LLC

Phase 2 Completed
275 enrolled 23 charts
Breast

Breast Neoplasms, Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon âš¡